(a) An unpolarised light source passes through a polariser to produce plane-polarised light (all electric-field oscillations now in a single plane). The plane-polarised light then passes through the sample cell containing the substance in solution. The emerging light passes through a second polariser (the analyser), whose orientation is rotated until minimum light intensity is transmitted. The angle through which the analyser has been rotated relative to its starting (crossed) position is the optical rotation, α, produced by the sample.
(b) A racemic mixture is a 1 : 1 (equimolar) mixture of the two enantiomers. Even a pure sample of the 'safe' enantiomer of thalidomide is slowly interconverted (racemised) in the body under physiological conditions, so both enantiomers are again present in the blood after dosing. Marketing only the safe enantiomer therefore still delivers the teratogenic form and does not remove the risk.
(c) (i) Chiral chromatography (HPLC on a chiral stationary phase); the two enantiomers interact differently with the chiral packing and elute at different times, and the desired fraction is collected. [Alternatively: react the racemate with a single-enantiomer reagent to form two diastereoisomers, separate them by ordinary crystallisation or distillation, then regenerate the enantiomers.]
(ii) Asymmetric synthesis: use a chiral catalyst (or enzyme) whose chiral environment directs the reaction to give only the desired enantiomer.
(iii) Separation of a racemate wastes 50 % of the material as the unwanted enantiomer; asymmetric synthesis gives essentially 100 % of the desired enantiomer (higher yield, better atom economy, lower cost per gram at scale).
(d) Any one, e.g. L-DOPA: only the L (S) enantiomer treats Parkinson's disease — the D-enantiomer is inactive/harmful. [Also creditable: ibuprofen (only S-enantiomer active); (R)-(−)-carvone smells of spearmint but (S)-(+)-carvone smells of caraway (a flavouring rather than a drug, but the same chirality point).]